UPLC-MS/MS Determination of Aceclofenac and Diclofenac in Bulk, Dosage forms and in At-line Monitoring of Aceclofenac Synthesis
Ramzia I. El-Bagary, Hassan M. E. Azzazy, Ehab F. ElKady, Faten Farouk
Journal of Pharmaceutical Research International · pp. 1311–1331 · Published 23 May 2014
10.9734/BJPR/2014/5676Abstract
Aim: The derivatization product of diclofenac (DCL), aceclofenac (ACL), is a non-steroidal anti-inflammatory drug (NSAID) which causes faster and extended action with reduced gastrointestinal (GI) inflammation. The detection of DCL in ACL bulk and pharmaceutical products indicates incomplete synthesis and hydrolysis. In this article we have developed a UPLC-MS/MS method for analysis of ACL and DCL. The method was designed as an at-line monitoring tool for process analytical technology (PAT) application to ACL synthesis. The method was also applied for analysis of ACL and DCL in bulk and tablets. Methodology: Isocratic elution was performed on a UPLC C18 column (2.1 x 50 mm, 1.7 µm) using a mobile phase consisting of acetonitrile, water and formic acid (80:20:0.5, v/v/v). Flow rate was 0.2 mL/min and total run time was 1 min. Auto-sampler temperature was maintained at 5ºC to prevent any further degradation of ACL. Electrospray positive ionization (ESI +Ve) in multiple-reaction monitoring mode (MRM) was used for the simultaneous determination of ACL and DCL. Monitoring was performed at [M+H]+ 354.23: 250.09 and 296.13:250.1 m/z; respectively. The method was validated according to ICH guidelines Q2(R1). Results: The linearity range was 20 – 3000 ng/mL for both drugs. The developed method was accurate and precise (RSD<2%) for the determination of ACL and DCL in single solution (99.65±1.33 and 100.37±1.02 for ACL and DCL; respectively) and laboratory prepared mixtures (101.01±1.07 and 100.45±1.54 for ACL and DCL; respectively). The method was applied to Bristaflam® and Cataflam® tablets and the recovery was 100.95±0.18 and 99.15±0.62; respectively. The average recovery from reaction mixture was101.21±0.06 and 98.89±0.64 for ACL and DCL; respectively. Conclusion: The proposed UPLC-MS/MS method is valid for at-line monitoring of ACL and DCL during PAT application to ACL synthesis and drug determination in bulk and tablets.
Cited by 3
Rehab O. El-Attar, Ahlam M. Fathi, Ibrahim H.I. Habib · Egyptian Pharmaceutical Journal · 2024
Maria Cristina Gaudiano, Anna Borioni, Eleonora Antoniella · Journal of Forensic Sciences · 2016
Dalia Mohamed, Maha A. Hegazy, Mona S. Elshahed · Biomedical Chromatography · 2018
Related research
- Evaluation of Anti-inflammatory Activities of Erythrococca anomala Aqueous and Ethanolic Extracts from Leaves in Rat — shares topic coverage
- Evaluation of Anti-Inflammatory Activities of Aqueous and Ethanolic Extracts of Gomphrena celosioides Linn. — shares topic coverage
- Comparative Assessment of the Gastrointestinal Tolerability, Anti-inflammatory and Antipyretic Effects of Diclofenac, Ibuprofen and Nimesulide in White Albino Rats — shares topic coverage
- Anti-inflammatory Activities of the Chloroform Extract of the Fruit of Tetracarpidium conophorum (Mull. Arg.) (Nigerian Walnuts) — shares topic coverage
- Analgesic Effects of Vigna unguiculata subsepecies dekindtiana in Mice — shares topic coverage
Article metrics
Real usage data collected on this platform.
6
Page views
0
PDF downloads
0
Outbound clicks
3
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.